Stay current on changes and developments in corporate law with a wide variety of resources and tools.
April 5 — Investors are challenging TransCanada Corp.'s $10.2 billion proposed acquisition of Columbia Pipeline Group Inc., saying the deal is the “product of a hopelessly flawed process” that undervalues the company and its prospects.
Columbia's board and management and its largest shareholder, JPMorgan Chase & Co., are driving a proposed acquisition that will provide them with preferential benefits, the investors alleged in their would-be class action filed March 30 in the Delaware Chancery Court.
According to the complaint, the deal process was tainted by conflict. The investors said that JPMorgan will be able to cash in on over $1.1 billion of its illiquid Columbia holdings and that Columbia officers and directors stand to receive millions of dollars in special benefits if the deal goes through.
The lawsuit asserts breach of fiduciary duty claims against Columbia directors and aiding and abetting claims against TransCanada. The investors seek injunctive relief barring the proposed acquisition, unless the company adopts measures to obtain the highest possible deal price.
Columbia representatives didn't immediately respond to Bloomberg BNA's request for comment.
On March 17, the companies announced that TransCanada had agreed to pay $25.50 per share to Columbia holders, in a deal to help the company expand its gas pipeline business . The deal price represented a 11 percent premium on the company's March 16 closing price.
The investors claimed that the deal was timed to allow TransCanada to take advantage of a downturn in the energy market. Their complaint said the company's stock traded at a market high of $33 per share in June 2015.
“CPG’s prospects are excellent and growing,” the filing said. “But rather than pursue the Company’s current strategy, with its strong prospects, the Board agreed, for its own interests, to sell CPG on the cheap, ignoring its duty to maximize stockholder value.”
In addition to challenging the deal process, the investors assert that the merger agreement contains measures that illegally foreclose topping bids.
To contact the reporter on this story: Michael Greene in Washington at firstname.lastname@example.org
To contact the editor responsible for this story: Yin Wilczek at email@example.com
The complaint is available at http://www.bloomberglaw.com/public/document/Stephen_M_Vann_vs_Columbia_Pipeline_Group_Inc_Docket_No_12152_Del.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)